Production processClosed Production

Products 21 to 30 of 174

Bio-based Polybutylene Succinate by GC Innovation America + Myriant
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: Japan + China + Korea + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/09 16:26 (2 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:28 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:29 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Personal Care
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
BIO-SA Based Phthalate-Free Plasticizers by LANXESS + BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Germany
Country of distribution: USA + Germany
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/09 16:28 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: LXS (XETRA)
Value chain stage: N/A
BIO-SA Based Polyurethanes by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:29 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA Based Resins & Coatings by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: Benelux + France + Iberia + Germany + Poland + Switzerland + UK + Ireland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:30 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
BIO-SA Based Solvents by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/09 16:31 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
BIO-SA Brand Flavor Enhancers by BioAmber, Inc.
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:31 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
BIO-SA De-icing solutions by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: North America
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:26 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2B
Country of production: Canada
Country of distribution: Canada + France
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:32 (2 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input